Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2014-09-10 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
重庆臻跃生物科技有限公司等七家单位审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for 重庆臻跃生物科技有限公司 and six other units, covering the period from January 1, 2013 to August 25, 2014. It includes detailed audit opinions, financial statements such as balance sheets and income statements, and extensive notes on accounting policies and estimates. The document is 27 pages long and contains comprehensive financial data and auditor's responsibilities and opinions. This matches the definition of an Audit Report / Information (AR), which is a standalone audit report including applied accounting principles and audit results, distinct from a full Annual Report. The document is not a brief announcement or a certification letter, but a full audit report with financial statements and notes. Therefore, the correct classification is AR with high confidence. Q3 2014
2014-09-10 Chinese
拟收购上海嘉意国际贸易有限公司等九家公司项目资产评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an "资产评估报告" which translates to "Asset Valuation Report" or "Asset Appraisal Report." It is prepared by a professional asset appraisal company for 嘉事堂药业股份有限公司 regarding its planned acquisition of nine companies including 上海嘉意国际贸易有限公司. The report includes detailed valuation methods such as asset-based and income approaches, valuation dates, scope, assumptions, and conclusions about the market value of the combined entity's equity. The document is lengthy (15,000 characters) and contains substantive financial and valuation data, not merely an announcement or summary. It is not a general annual report, earnings release, or management discussion, nor is it a regulatory filing or certification. It is a standalone asset valuation report related to a merger/acquisition transaction, but it is not a merger proxy or tender offer filing. Given the specific nature of the document as an asset valuation report supporting an acquisition, the most appropriate classification is "Audit Report / Information (AR)" because it is a standalone professional valuation report, which is distinct from full annual reports or merger filings. Q3 2014
2014-09-10 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator company regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and declarations related to the nominee's independence and eligibility. There is no financial data, no report of financial results, no voting results, no management changes announcement, and no mention of any report publication or regulatory filing. The content is focused on board/management information specifically about the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length and detail support this classification with high confidence.
2014-09-10 Chinese
独立董事提名人声明（二）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with legal and regulatory requirements, and independence criteria of the nominee. There is no financial data, no discussion of financial results, no mention of annual or interim reports, earnings, or capital changes. The content focuses on board member nomination and compliance with governance rules. This fits the category of Board/Management Information (MANG), which covers announcements of changes or nominations in the company's board of directors or senior management.
2014-09-10 Chinese
关于召开2014年第一次临时股东大会的通知公告（已取消）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2014 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items including proposals for convertible bond issuance, amendments to company articles, election of board members and supervisors, and instructions for shareholders on how to register and vote. The document does not contain financial statements or results but is a formal announcement to shareholders about the meeting and voting process. This fits the definition of a Proxy Solicitation & Information Statement (PSI), as it provides materials sent to shareholders to inform and request votes for the meeting. It is not a report publication announcement since it contains substantive meeting and voting details, nor is it a declaration of voting results (DVA) since it precedes the meeting. Therefore, the correct classification is PSI with high confidence.
2014-09-10 Chinese
关于与北京海淀置业集团有限公司的关联交易公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction between the company and Beijing Haidian Real Estate Group Co., Ltd. It details the terms of a property lease agreement, the approval by the board of directors, and the independent directors' opinions. There are no financial statements or comprehensive financial data presented. The document is relatively short (2392 characters) and serves as a disclosure of a specific transaction rather than a full financial report or management discussion. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement about a related party transaction, which is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit more specific categories.
2014-09-10 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.